CONMED CORP (CNMD) Stock Income Statement
NYSE:CNMD - New York Stock Exchange, Inc. - US2074101013 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.32B | 1.31B | 1.24B | 1.05B | 1.01B | |||
| Cost Of Goods | 577.18M | 573.98M | 568.50M | 474.20M | 442.60M | |||
| Gross Profit | 738.82M | 733.03M | 676.25M | 571.20M | 568.00M | |||
| Operating Expenses | 546.94M | 523.83M | 554.84M | 501.20M | 457.90M | |||
| Research and Development | 53.78M | 54.43M | 52.60M | 47.20M | 43.60M | |||
| Selling, General, and Administrative Expenses | 468.97M | 371.38M | 296.84M | 420.30M | 381.00M | |||
| Operating Income | 191.88M | 209.20M | 121.40M | 70.10M | 110.10M | |||
| Interest Income/Expense | -35.99M | -37.30M | -39.77M | -28.90M | -35.50M | |||
| Other Income/Expense | N/A | 0.00 | 0.00 | -8.90M | -1.13M | |||
| Non Recurring Items | -10.61M | -8.88M | -800.00K | -103.10M | -1.50M | |||
| Income Before Taxes | 145.28M | 163.03M | 80.83M | -70.90M | 73.10M | |||
| Income Tax | 26.53M | 30.61M | 16.37M | 9.70M | 10.60M | |||
| Net Income | 118.75M | 132.42M | 64.46M | -80.60M | 62.50M | |||
| EBITDA | 263.95M | 281.06M | 193.28M | 139.70M | 180.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 3.82 | 4.25 | 2.04 | -2.68 | 1.94 | |||
| Non GAAP EPS | 4.32 | 4.16 | 3.45 | 2.65 | 3.21 | |||
| Statistics | ||||||||
| Gross Profit Margin | 56.14% | 56.08% | 54.33% | 54.63% | 56.20% | |||
| Profit Margin | 9.02% | 10.13% | 5.18% | -7.71% | 6.18% | |||
| Operating Profit Margin | 14.58% | 16.01% | 9.75% | 6.70% | 10.89% | |||
All data in USD